Header Logo

Connection

DAVID BATES to Phosphodiesterase 5 Inhibitors

Back to Details
This is a "connection" page, showing publications DAVID BATES has written about Phosphodiesterase 5 Inhibitors.
DAVID BATES
Connection Strength
0.051
Phosphodiesterase 5 Inhibitors
  1. Phosphodiesterase type 5 inhibitors enhance chemotherapy in preclinical models of esophageal adenocarcinoma by targeting cancer-associated fibroblasts. Cell Rep Med. 2022 06 21; 3(6):100541.
    View in: PubMed
    Score: 0.051
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.